Managing the transition to CFC-free inhalers.
Asthma inhalers which use CFC propellants will be replaced by CFC-free devices within three years. Research suggests that inflammation in the small airways is often inadequately treated. CFC-free steroid-based inhalers appear to increase total lung deposition and peripheral lung penetration.